Prevalence and Patterns of Medication Use Among Older Adults in the US: Findings from a National Population-based Study - PowerPoint PPT Presentation

1 / 16
About This Presentation
Title:

Prevalence and Patterns of Medication Use Among Older Adults in the US: Findings from a National Population-based Study

Description:

Prevalence and Patterns of Medication Use Among Older Adults in the US: Findings from a National Population-based Study Dima Qato, PharmD, MPH – PowerPoint PPT presentation

Number of Views:163
Avg rating:3.0/5.0
Slides: 17
Provided by: ims94
Category:

less

Transcript and Presenter's Notes

Title: Prevalence and Patterns of Medication Use Among Older Adults in the US: Findings from a National Population-based Study


1
Prevalence and Patterns of Medication Use
Among Older Adults in the US Findings from a
National Population-based Study
  • Dima Qato, PharmD, MPH
  • G. Caleb Alexander MD, MS
  • Rena M. Conti, PhD
  • Michael Johnson, BA
  • Phil Schumm, MA
  • Stacy Tessler Lindau, MD, MAPP
  • The University of Chicago, Chicago, Illinois

Academy Health Annual Research Meeting, June 2008
2
Objectives
  • Determine recent prevalence and patterns of
    medication use in the elderly
  • Assess medication-related quality of care

3
Background
  • 92 of elderly have a prescription drug expense.
  • 13 use Rxs concurrently with alternative
    medicines
  • 21 use 5 or more Rx medications
  • Elderly increased risk for Adverse Drug Events
    (ADE).
  • ADE-related hospitalizations/ER visits most
    commonly due to GI bleeding
  • Increase in Medicare spending on Rx drugs (2 in
    2005 to 18 in 2006)

Kaiser Family Foundation, 2007 Catlin, et al,
2008 Kaufman et al 2002 Gardiner et al 2006
Becker et al, 2007 Budnitz et al, 2007
4
Limitations of available medication data sources
  • Claims/administrative data
  • Only patients with access to health care
  • Only prescribed/dispensed medications
  • Do not measure actual drug use (ingestion)
  • Do not focus on elderly (aggregate adults 65 and
    older)
  • Do not measure use of all types of medications.
  • Outdated (do not account for new medications that
    enter market)

5
Study Methods
  • Data National, Social life, Health, and Aging
    Project (NSHAP)- Wave I (2005-2006)
  • In-home interview of 3,005 community-residing
    adults ages 57-85
  • Nationally-representative population-based
    probability sample minority over-sampling
    response rate75.5
  • Weighted-estimates
  • Universe Directly-observed Medication log
  • medications currently used on a regular
    schedule, like every day or every week. Including
    prescription, OTC, vitamins, herbals and
    alternative medicines.
  • Drug name matching rate97
  • Micromedex Interaction software

6
Prevalence of use Measures
  • Prescription medication use use of at least one
    medication available only with a prescription.
  • Over-the-counter use Use of non-prescription
    medication that is not a dietary supplement.
  • Dietary supplement use use of a nutritional
    product or alternative medicine.

Patterns of use Measures
  • Poly-pharmacy use of 5, 10 Rx
    medications
  • Concurrent use use of a Rx medication
    concurrently with a non-Rx
  • medication
  • Quality of Care Measure
  • Major medication interaction a drug-drug
    interaction of potentially
  • Major severity as defined by Micromedex
    among users of the 20 most
  • common Rx and OTC drugs and 20 most common CAM
    therapies.

7
Rx and OTC Medications Commonly Used ( 5) by
Adults 65 and older (1999 vs.2005)
Slone (1998-1999) Slone (1998-1999)
1 Aspirin
2 Acetaminophen
3 Conjugated estrogens
4 Hydrochlorthiazide
5 Levothyroxine
6 Furosemide
7 Ibuprofen
8 Atenolol
9 Lisinopril
10 Digoxin
11 Warfarin
12 Triamterine
NSHAP (2005-2006) NSHAP (2005-2006) NSHAP (2005-2006) NSHAP (2005-2006)
1 Aspirin 13 Warfarin
2 Hydrochlorothiazide 14 Ezetimibe
3 Levothyroxine 15 Alendronate
4 Lisinopril 16 Lovastatin
5 Atorvastatin 17 Valsartan
6 Metoprolol 18 Omeprazole
7 Simvastatin
8 Atenolol
9 Amlodipine
10 Acetaminophen
11 Furosemide
12 Metformin
8
Most commonly used ( 3) Dietary Supplements
Among Adults 65 and older (1999 vs.2005)
NSHAP(2005-2006) NSHAP(2005-2006)
1 Multivitamin/mineral
2 Calcium
3 Vitamin E
4 Vitamin C
5 Glucosamine
6 Vitamin B12
7 Folic Acid
8 Vitamin D
9 Chondroitin
10 Omega 3 Fatty Acids
11 Vitamin B6
12 Eye Vitamins
13 Magnesium
Slone (1998-1999) Slone (1998-1999)
1 Multivitamin/mineral
2 Vitamin E
3 Calcium
4 Vitamin C
5 Vitamin D
6 Magnesium
7 Glucosamine
8 Folic Acid
9 Ginkgo
10 Garlic
11 Zinc
9
(No Transcript)
10
(No Transcript)
11
Medication Interaction Severity Definitions
  • major life-threatening and/or require medical
    intervention to minimize or prevent serious
    adverse events.
  • moderate may result in the exacerbation of the
    patients condition.
  • minor the interaction would have limited
    clinical effects.

12
Prevalence of Potentially Harmful Medication
Interactions
13
Limitations
  • Cross sectional data
  • Comparability to previous studies
  • Micromedex Interaction software
  • Major Interactions reported only for commonly
    used medications.

14
Conclusions
  • Overall increase in the prevalence of medication
    use and number of commonly used medications among
    older adults
  • Types of commonly used Rx, OTC, and dietary
    supplements varies over time
  • Poly-pharmacy is common and increases with age
  • Self-medication with NonRx is widespread across
    all older age groups
  • Approximately 2.2 million (4) older adults in
    the U.S. are at risk for a harmful medication
    interaction
  • Half are potentially at risk for GI bleeding

15
Implications
  • Up-to-date data on medication use among older
    adults increasingly important in the assessment
    of medication-related Quality of care
  • National prescription data sources need to
    incorporate information on all types of
    medications
  • Efforts to minimize harmful interactions should
    focus on common medications with the highest risk
    and the oldest age group
  • Patient safety in older adults requires clinician
    awareness of current prescription medication and
    self-medication use patterns

16
  • Supported by
  • The University of Chicago Program in
    Pharmaceutical Policy
  • Chicago Core on Biomeasures in Population-Based
    Health and Aging Research, Center on Demography
    and Economics of Aging, NORC and the University
    of Chicago (P30 AG 012857)
  • National Institute of Health and the National
    Institute on Aging, Office of Research on Women's
    Health Office of AIDS Research, and Office of
    Behavioral and Social Sciences Research
    (R01AG021487)
  • Public use dataset available at
  • http//www.icpsr.umich.edu/NACDA
Write a Comment
User Comments (0)
About PowerShow.com